the latest from sequence bio

news and press

• December 16, 2024 | St. John's, Newfoundland & Labrador

  Sequence Bio and Memorial University collaborate to study the genetics of multiple sclerosis

• September 20, 2024 | St. John's, Newfoundland & Labrador

  Sequence Bio launches genetics study of familial multiple sclerosis

• October 26, 2023 | St. John's, Newfoundland & Labrador

  NL Health Services selects Sequence Bio as an Innovation Partner

• October 29, 2024 | St. John’s, Canada

  New study details ancestry and other contributions to the genetic substructure of the Newfoundland and Labrador founder population

• May 15, 2023 | Dublin, Ireland; St. John’s, Canada

  New study illustrates unique genetic landscape in Newfoundland and Labrador with links to Ireland and England

• September 5, 2023 | St. John's, Newfoundland & Labrador

  Sequence Bio appoints Lynn Healey as Chief Executive Officer

• November 1, 2023 | St. John's, Newfoundland & Labrador

  Sequence Bio research posters selected for presentation at ASHG 2023

• April 7, 2022 | St. John's, Newfoundland & Labrador

  Sequence Bio announces Discovery Collaboration Agreement with LEO Pharma

• October 27, 2022 | St. John's, Newfoundland & Labrador

  Dr. Bari Ballew joins Sequence Bio as Senior Director, Data Science & Analytics

• April 5, 2022 | St. John's, Newfoundland & Labrador

  Sequence Bio named one of Canada’s Top Small & Medium Employers

• October 29, 2021 | St. John's, Newfoundland & Labrador

  Sequence Bio invited to present at ASHG 2021

• October 26, 2021 | St. John's, Newfoundland & Labrador

  Sequence Bio recognized with Women in Tech Advocate Award

• June 11, 2021 | St. John's, Newfoundland & Labrador

  Sequence Bio Selected to Present at BIO Digital 2021

• May 20, 2021 | St. John's, Newfoundland & Labrador

  Brendan Paddick Leads Investment in Sequence Bio, Appointed to Board of Directors

• April 21, 2021 | St. John's, Newfoundland & Labrador

  Lynn Healey joins Sequence Bio as Chief Financial Officer

• October 26, 2020 | St. John's, Newfoundland & Labrador

  Sequence Bio posters selected for ASHG 2020, the world's largest human genetics and genomics meeting

• August 12, 2020 | St. John's, Newfoundland & Labrador

  Dr. Michael S. Phillips, CSO, to present at Congenica’s Enabling Genomic Medicine 2020

• September 5, 2019 | St. John's, Newfoundland & Labrador

  Sequence Bio welcomes Joy Buckle as Vice President of Policy and Planning

• August 23, 2019 | St. John's, Newfoundland & Labrador

  Sequence Bio receives investment from Y Combinator and joins their exclusive founder network

• July 24, 2019 | St. John's, Newfoundland & Labrador

  Sequence Bio begins search for better, safer medicines and disease treatments with launch of the NL Genome Project.

• August 14, 2018 | St. John's, Newfoundland & Labrador and Moncton, New Brunswick

  Sequence Bio receives approval for research in New Brunswick

• January 16, 2018 | St. John's, Newfoundland and Labrador

  Sequence Bio appoints Dr. Michael S. Phillips as Chief Scientific Officer to lead genomic research and drug discovery projects.

• November 28, 2017 | St. John's, Newfoundland and Labrador

  Sequence Bio CEO named to federal Economic Strategy Table

• September 26, 2017 | Washington, DC & St. John's, NL

  Sequence Bio announces Dr. Kathy Hudson as Chair of Scientific Advisory Board

• May 8, 2017 | St. John's, Newfoundland and Labrador

  Sequence Bio recognizes the Honourable Jim Cowan for leadership in preventing genetic discrimination with Bill S-201

© 2025 Sequence Bio, Inc. All Rights Reserved.

Social

• Facebook
• Twitter
• Linkedin

Keep in touch